共 50 条
- [34] Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : 861 - 872
- [36] Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 265.e1 - 265.e9
- [38] Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1307 - 1314